Omnia SanaPlant Comparison
Saffron vs Holy Basil
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Saffron and Holy Basil: they share 7 indicated uses (arthritis / joint pain, blood sugar / diabetes support, cancer (anticancer research), …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Saffron | Holy Basil | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Blood sugar / diabetes support | 1/10 | 7/10 | Stronger for Holy Basil |
| Cancer (anticancer research) | 8/10 | 8/10 | Comparable evidence |
| Cognitive function | 1/10 | 5/10 | Stronger for Holy Basil |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Memory | 1/10 | 5/10 | Stronger for Holy Basil |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Water-soluble carotenoid glycosides responsible for saffron's deep golden-red colour and much of its antioxidant and mood-related activity.
The principal volatile aromatic compound, giving saffron its characteristic scent and contributing to its sedative and antidepressant activity.
The main bitter-tasting glycoside of the stigma, a precursor of safranal.
Pharmacological Actions
Adaptogen for stress and anxiety (improves stress scores and well-being in trials)
Cognitive support - a placebo-controlled study in healthy adults found improved reaction time and accuracy and shorter P300 latency
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from neuroprotective action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antidiabetic action
Adaptogen for stress and anxiety (improves stress scores and well-being in trials)
inferred from anti-inflammatory action
Supports blood-sugar control (lowers fasting and post-meal glucose)
inferred from anticancer action
inferred from neuroprotective action
inferred from adaptogen action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Culinary use is entirely safe. At very high doses (5g+), saffron can be toxic — but such doses far exceed culinary or therapeutic amounts. Avoid medicinal doses during pregnancy (uterine stimulant). May interact with antidepressants. High quality saffron is often adulterated; verify source.
Duke (2002) rates saffron as ++ and provides a critical safety warning: abortifacient activity has clinical support (score 2), meaning that medicinal doses can induce abortion — saffron is strictly contraindicated in pregnancy at doses above culinary amounts. The plant also shows antidepressant, antioxidant, and antitumor activities at the experimental level (score 1). Dose (culinary): 0.5 g stigmas as flavoring; medicinal doses above 5 g are considered potentially toxic. Duke notes that saffron stigmas contain crocin and safranal, which are responsible for its antidepressant and antioxidant properties (Duke, 2002).
Generally well tolerated; mild nausea has been reported. Its blood-sugar-lowering effect means caution alongside antidiabetic medicines.
External Ids
Botanical Description
Small, cormous perennial with narrow, grass-like, dark green leaves emerging with or just after the flowers. Each flower is a delicate lilac-purple, six-petalled bloom with three golden-yellow anthers and a single style dividing into three long, deep-red, thread-like stigmas - the saffron of commerce. The plant is a sterile triploid that never sets seed and is propagated entirely by division of its underground corms.
Aromatic annual or short-lived perennial subshrub (Lamiaceae), 30-75 cm tall, with erect, much-branched, hairy stems often tinged purple. Leaves are opposite, ovate-oblong with a toothed margin, and release a strong, clove-like (eugenol) scent when crushed. Small purplish-pink, two-lipped flowers are borne in elongated terminal racemes. The plant is held sacred in Hindu tradition (Tulsi).[11]
Habitat
Believed to have originated in Greece or Crete and spread through cultivation across the Mediterranean, Middle East and Asia (notably Iran, Kashmir and Spain); grown in sunny, well-drained fields with hot, dry summers and cool, wet autumns/winters.
Native to the Indian subcontinent and tropical Asia, now cultivated and naturalised throughout the tropics and subtropics worldwide; commonly grown in home gardens and temple courtyards as well as cultivated as a medicinal and aromatic crop.[12]
Harvesting
The flowers are hand-picked at dawn as they open, and the three red stigma threads are immediately hand-separated from each flower and dried - an extremely labour-intensive process (many thousands of flowers are needed for a small amount of dried saffron), which accounts for saffron's high cost.
Leaves are harvested year-round from actively growing plants, ideally picked once morning dew has dried; whole flowering tops are also gathered.
Traditional Uses
Saffron has a long Mediterranean, Middle Eastern and South Asian tradition as both a prized culinary spice/dye and a medicinal herb, used for mood support, digestive complaints and as a mild emmenagogue; its traditional mood-lifting reputation is now supported by clinical trials comparing standardised saffron extract to conventional antidepressants for mild-to-moderate depression.[1]
Tulsi is one of the most revered plants in Ayurvedic medicine, traditionally used as an adaptogen for stress, a remedy for respiratory complaints (colds, cough, asthma), and a general immune tonic. Modern clinical trials support adaptogenic/anti-stress, blood-sugar-lowering and immunomodulatory effects consistent with these traditional uses.[3, 12]
Preparations
Stigma extract standardised to safranal/crocin content, taken as capsules; the form used in most clinical mood and metabolic studies.
Dosage
Clinical trials for mood support commonly use around 30 mg of standardised saffron extract daily (in divided doses); culinary use is typically well under 1 g. High medicinal doses (5 g or more) are considered potentially toxic and should be avoided. Educational reference only, not a prescription.
Clinical trials for stress and mood have used standardised dry-extract capsules taken over several weeks; dosing varies by product concentration, so follow the manufacturer's guidance. Educational reference only, not a prescription.
The WHO monograph on Folium Ocimi Sancti gives a daily dosage of 6-12 g of the crude drug as a decoction. This is a whole-day total for the fresh or dried leaf, notably higher than the 1-2 g per cup often quoted in popular sources. Educational reference only, not a prescription.
References
Drug Class Interactions
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Shafiee, A., Jafarabady, K., Seighali, N., Mohammadi, I. et al (2025) 'Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment of Depression and Anxiety: A Meta-analysis of Randomized Controlled Trials', Nutrition Reviews, 83(3), pp. e751-e761. doi:10.1093/nutrit/nuae076 Meta-analysis / review
https://doi.org/10.1093/nutrit/nuae076 - Lopresti, A.L. and Drummond, P.D (2014) 'Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action', Human Psychopharmacology, 29(6), pp. 517-527. doi:10.1002/hup.2434 Meta-analysis / review
https://doi.org/10.1002/hup.2434 - Chen, Z., Gu, J., Lin, S., Xu, Z. et al (2022) 'Saffron essential oil ameliorates CUMS-induced depression-like behavior in mice via the MAPK-CREB1-BDNF signaling pathway', Journal of Ethnopharmacology, 300, pp. 115719. doi:10.1016/j.jep.2022.115719 Preclinical
https://doi.org/10.1016/j.jep.2022.115719 - Hausenblas, H.A., Saha, D., Dubyak, P.J. and Anton, S.D (2013) 'Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials', Journal of Integrative Medicine, 11(6), pp. 377-383. doi:10.3736/jintegrmed2013056 Meta-analysis / review
https://doi.org/10.3736/jintegrmed2013056 - Kell, G., Rao, A., Beccaria, G., Clayton, P., Inarejos-Garcia, A.M. and Prodanov, M (2017) 'affron a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial', Complementary Therapies in Medicine, 33, pp. 58-64. doi:10.1016/j.ctim.2017.06.001 Randomized trial
https://doi.org/10.1016/j.ctim.2017.06.001 - Baziar, S., Aqamolaei, A., Khadem, E., Mortazavi, S.H., Naderi, S., Sahebolzamani, E., Mortezaei, A., Jalilevand, S., Mohammadi, M., Shahmirzadi, M. and Akhondzadeh, S (2019) 'Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study', Journal of Child and Adolescent Psychopharmacology, 29(3), pp. 205-212. doi:10.1089/cap.2018.0146 Randomized trial
https://doi.org/10.1089/cap.2018.0146 - Moshiri, M., Vahabzadeh, M. and Hosseinzadeh, H (2014) 'Clinical Applications of Saffron (Crocus sativus) and its Constituents: A Review', Drug Research, 65(6), pp. 287-295. doi:10.1055/s-0034-1375681 Meta-analysis / review
https://doi.org/10.1055/s-0034-1375681 - Finley, J.W. and Gao, S (2017) 'A Perspective on Crocus sativus L. (Saffron) Constituent Crocin: A Potent Water-Soluble Antioxidant and Potential Therapy for Alzheimer's Disease', Journal of Agricultural and Food Chemistry, 65(5), pp. 1005-1020. doi:10.1021/acs.jafc.6b04398 Meta-analysis / review
https://doi.org/10.1021/acs.jafc.6b04398 - Boskabady, M.H. and Farkhondeh, T (2016) 'Antiinflammatory, Antioxidant, and Immunomodulatory Effects of Crocus sativus L. and its Main Constituents', Phytotherapy Research, 30(7), pp. 1072-1094. doi:10.1002/ptr.5622 Meta-analysis / review
https://doi.org/10.1002/ptr.5622 - Bhandari, P.R (2015) 'Crocus sativus L. (saffron) for cancer chemoprevention: A mini review', Journal of Traditional and Complementary Medicine, 5(2), pp. 81-87. doi:10.1016/j.jtcme.2014.10.009 Meta-analysis / review
https://doi.org/10.1016/j.jtcme.2014.10.009 - Khorasanchi, Z., Shafiee, M., Kermanshahi, F., Khazaei, M., Ryzhikov, M., Parizadeh, M.R., Kermanshahi, B., Ferns, G.A., Avan, A. and Hassanian, S.M (2018) 'Crocus sativus a natural food coloring and flavoring has potent anti-tumor properties', Phytomedicine, 43, pp. 21-27. doi:10.1016/j.phymed.2018.03.041 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2018.03.041 - El Midaoui, A., Ghzaiel, I., Vervandier-Fasseur, D., Ksila, M., Zarrouk, A., Nury, T., Khallouki, F., El Hessni, A., Ibrahimi, S.O., Latruffe, N., Couture, R., Kharoubi, O., Brahmi, F., Hammami, S., Masmoudi-Kouki, O., Hammami, M., Ghrairi, T., Vejux, A. and Lizard, G (2022) 'Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Treatment of Neuropsychiatric and Age-Related Diseases', Nutrients, 14(3), pp. 597. doi:10.3390/nu14030597 Meta-analysis / review
https://doi.org/10.3390/nu14030597 - Pitsikas, N (2021) 'Crocus sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?', Molecules, 26(5), pp. 1237. doi:10.3390/molecules26051237 Meta-analysis / review
https://doi.org/10.3390/molecules26051237 - Akhondzadeh, S. et al (2005) 'Comparison of Crocus sativus L'. Traditional / reference
https://scholar.google.com/scholar?q=Comparison%20of%20Crocus%20sativus%20L - Hosseinzadeh, H. and Nassiri-Asl, M (2013) 'Avicenna', 27(4), pp. 475--483. Traditional / reference
https://scholar.google.com/scholar?q=Avicenna - Moshiri, E. et al (2006) 'Crocus sativus L', pp. 607--611. Traditional / reference
https://scholar.google.com/scholar?q=Crocus%20sativus%20L - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Talaei, A., Hassanpour Moghadam, M., Sajadi Tabassi, S.A. and Mohajeri, S.A (2015) 'Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial', Journal of Affective Disorders, 174, pp. 51-56. doi:10.1016/j.jad.2014.11.035 Randomized trial
https://doi.org/10.1016/j.jad.2014.11.035 - Toth, B., Hegyi, P., Lantos, T., Szakacs, Z., Keremi, B., Varga, G., Tenk, J., Petervari, E., Balasko, M., Rumbus, Z., Rakonczay, Z., Balint, E.R., Kiss, T. and Csupor, D (2019) 'The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis', Planta Medica, 85(1), pp. 24-31. doi:10.1055/a-0660-9565 Meta-analysis / review
https://doi.org/10.1055/a-0660-9565 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003 - Liu, J., Yang, Y. and Qi, Y (2024) 'Effect of saffron supplementation on the glycemic outcomes in diabetes: a systematic review and meta-analysis', Frontiers in Nutrition, 11, pp. 1349006. doi:10.3389/fnut.2024.1349006 Meta-analysis / review
https://doi.org/10.3389/fnut.2024.1349006 - Kupper, J. and Reichert, C (2009) 'Intoxications with plants', Therapeutische Umschau, 66(5), pp. 343-8. doi:10.1024/0040-5930.66.5.343 Clinical study
https://doi.org/10.1024/0040-5930.66.5.343 - Gabrscek, L. and Lesnicar, G. and Krivec, B. and Voga, G. and Sibanc, B. and Blatnik, J. and Jagodic, B (2004) 'Accidental poisoning with autumn crocus', Journal of Toxicology. Clinical Toxicology, 42(1), pp. 85-8. doi:10.1081/clt-120028750 Clinical study
https://doi.org/10.1081/clt-120028750 - University of Wisconsin-Madison Division of Extension 'Autumn Crocus, Colchicum spp'. Available at: https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/ Traditional / reference
https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/ - Ohio State University Extension (Buckeye Yard and Garden onLine) 'Crocus By Other Names'. Available at: https://bygl.osu.edu/node/1458 Traditional / reference
https://bygl.osu.edu/node/1458
- Lopresti, A.L., Smith, S.J., Metse, A.P. and Drummond, P.D (2022) 'A randomized, double-blind, placebo-controlled trial investigating the effects of an Ocimum tenuiflorum (Holy Basil) extract (Holixer) on stress, mood, and sleep in adults experiencing stress', Frontiers in Nutrition, 9, pp. 965130. doi:10.3389/fnut.2022.965130 Randomized trial
https://doi.org/10.3389/fnut.2022.965130 - Baliga, M.S., Jimmy, R., Thilakchand, K.R., Sunitha, V. and others (2013) 'Ocimum sanctum L (Holy Basil or Tulsi) and its phytochemicals in the prevention and treatment of cancer', Nutrition and Cancer, 65(Suppl 1), pp. 26-35. doi:10.1080/01635581.2013.785010 Meta-analysis / review
https://doi.org/10.1080/01635581.2013.785010 - Cohen, M.M (2014) 'Tulsi - Ocimum sanctum: A herb for all reasons', Journal of Ayurveda and Integrative Medicine, 5(4), pp. 251-259. doi:10.4103/0975-9476.146554 Meta-analysis / review
https://doi.org/10.4103/0975-9476.146554 - Arya, R., Faruquee, H.M., Shakya, H., Rahman, S.A. and others (2024) 'Harnessing the Antibacterial, Anti-Diabetic and Anti-Carcinogenic Properties of Ocimum tenuiflorum Linn (Tulsi)', Plants, 13(24), pp. 3516. doi:10.3390/plants13243516 Preclinical
https://doi.org/10.3390/plants13243516 - Prakash, P. and Gupta, N (2005) 'Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review', Indian Journal of Physiology and Pharmacology, 49(2), pp. 125-131. Meta-analysis / review
https://scholar.google.com/scholar?q=Therapeutic%20uses%20of%20Ocimum%20sanctum%20Linn%20%28Tulsi%29%20with%20a%20note%20on%20eugenol%20and%20its%20pharmacological%20actions%3A%20a%20short%20review - Jayapal, V., Vidya Raj, C.K., Muthaiah, M., Chadha, V.K. and others (2021) 'In-vitro anti-Mycobacterium tuberculosis effect of essential oil of Ocimum sanctum L. (Tulsi/Basil) leaves', Indian Journal of Tuberculosis, 68(4), pp. 470-473. doi:10.1016/j.ijtb.2021.02.009 Preclinical
https://doi.org/10.1016/j.ijtb.2021.02.009 - Baliga, M.S., Rao, S., Rai, M.P. and D'souza, P (2016) 'Radio protective effects of the Ayurvedic medicinal plant Ocimum sanctum Linn. (Holy Basil): A memoir', Journal of Cancer Research and Therapeutics, 12(1), pp. 20-27. doi:10.4103/0973-1482.151422 Meta-analysis / review
https://doi.org/10.4103/0973-1482.151422 - Kamel, F.O., Karim, S., Bafail, D.A.O., Aldawsari, H.M. and others (2023) 'Hepatoprotective effects of bioactive compounds from traditional herb Tulsi (Ocimum sanctum Linn) against galactosamine-induced hepatotoxicity in rats', Frontiers in Pharmacology, 14, pp. 1213052. doi:10.3389/fphar.2023.1213052 Preclinical
https://doi.org/10.3389/fphar.2023.1213052 - Yadav, I., Kumar, R., Fatima, Z. and Rema, V (2024) 'Ocimum sanctum (Tulsi) as a Potential Immunomodulator for the Treatment of Ischemic Injury in the Brain', Current Molecular Medicine, 24(1), pp. 60-73. doi:10.2174/1566524023666221212155340 Meta-analysis / review
https://doi.org/10.2174/1566524023666221212155340 - Kumar, P. and Patel, D (2023) 'Ocimum Sanctum: An All-Round Treatment for Cancer?', Alternative Therapies in Health and Medicine, 29(4), pp. 253-257. Meta-analysis / review
https://scholar.google.com/scholar?q=Ocimum%20Sanctum%3A%20An%20All-Round%20Treatment%20for%20Cancer%3F - Bhattacharyya, P. and Bishayee, A (2013) 'Ocimum sanctum Linn. (Tulsi): an ethnomedicinal plant for the prevention and treatment of cancer', Anti-Cancer Drugs. doi:10.1097/CAD.0b013e328361aca1 Traditional / reference
https://doi.org/10.1097/CAD.0b013e328361aca1 - Jamshidi, N. and Cohen, M.M (2017) 'The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature', Evidence-Based Complementary and Alternative Medicine. doi:10.1155/2017/9217567 Meta-analysis / review
https://doi.org/10.1155/2017/9217567 - World Health Organization (2002) 'Folium Ocimi Sancti'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Sampath, S., Mahapatra, S.C., Padhi, M.M., Sharma, R. and Talwar, A (2015) 'Holy basil (Ocimum sanctum Linn.) leaf extract enhances specific cognitive parameters in healthy adult volunteers: A placebo controlled study', Indian Journal of Physiology and Pharmacology, 59(1), pp. 69--77. Randomized trial
https://scholar.google.com/scholar?q=Holy%20basil%20%28Ocimum%20sanctum%20Linn.%29%20leaf%20extract%20enhances%20specific%20cognitive%20parameters%20in%20healthy%20adult%20volunteers%3A%20A%20placebo%20controlled%20study - Jamshidi, N. and Cohen, M.M (2017) 'The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature', Evidence-Based Complementary and Alternative Medicine, 2017, pp. 9217567. doi:10.1155/2017/9217567 Meta-analysis / review
https://doi.org/10.1155/2017/9217567 - Agrawal, P., Rai, V. and Singh, R.B (1996) 'Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus', International Journal of Clinical Pharmacology and Therapeutics, 34(9), pp. 406-409. Randomized trial
https://scholar.google.com/scholar?q=Randomized%20placebo-controlled%2C%20single%20blind%20trial%20of%20holy%20basil%20leaves%20in%20patients%20with%20noninsulin-dependent%20diabetes%20mellitus
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.